Phrase: "We will evaluate the implementation"
From: Warning letter 05-10 to Teva Parenterals
This warning concerns the testing of raw material lots. The FDA says in the letter that Teva failed to conduct such testing on each lot of the materials used in its propofol injectable emulsion anesthesia.
"Your firm's responses, dated August 10, September 4, and November 13, 2009, state that your firm will subject each lot of incoming raw material to full microbiological testing, including endotoxin testing," the FDA writes. "We will evaluate the implementation of this testing and verify that you are subjecting each lot of incoming raw materials to full microbiological testing during our next inspection."
Translation: "I'll be bahk."